
MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE
January 29, 2021
Last week, Salt Lake City (SLC) Mayor Erin Mendenhall gave her second State of the City address – a live broadcast from the City Council Chambers in which she reflected on 2020 and outlined her plan for the City in 2021.
The Mayor noted that “we are striving to make our city better through change; to come out of this pandemic stronger, more resilient, more equitable, and more just than before.”
The 2021 plan – Recharge, Reset, Rebound – includes several elements of interest to Utah’s life sciences industry:
- Drive forward Tech Lake City and BioHive initiatives, and pursue additional partnership opportunities to further grow and expand the life sciences industry.
- Work with healthcare innovation companies in SLC to create apprenticeships for our residents and,
- Explore SLC Airport advertising potential for BioHive, city-art assets, and neighborhood nodes.
“BioUtah applauds Mayor Medenhall’s vision, which recognizes the importance of Utah’s life sciences industry to the City now and for the future,” said Kelvyn Cullimore, president and CEO of BioUtah. “We look forward to working closely with the Mayor and her team to unleash the full potential of BioHive and healthcare innovation.”
BioHive is a new branding initiative aimed at raising the profile of the state’s life sciences industry on the national and global stage. BioHive is made possible due to a partnership with BioUtah, Salt Lake City Mayor Mendenhall, Governor’s Office of Economic Development, Economic Development Corporation of Utah, World Trade Center Utah, University of Utah’s PIVOT Center, Recursion, Cibus Biotechnologies, IONIQ Sciences, Stryker, LineLogic, and many others.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp














